Industry eyes will be focused on the Senate tomorrow (Thursday) with the vote on Sen. Richard Durbin's controversial amendment to the pending Food and Drug Administration (FDA) User Fee Act scheduled for 2pm EST.
Categories
Industry eyes will be focused on the Senate tomorrow (Thursday) with the vote on Sen. Richard Durbin's controversial amendment to the pending Food and Drug Administration (FDA) User Fee Act scheduled for 2pm EST.